SAIA, FRANCESCO
 Distribuzione geografica
Continente #
NA - Nord America 7.340
AS - Asia 6.896
EU - Europa 5.493
AF - Africa 633
SA - Sud America 507
OC - Oceania 10
Continente sconosciuto - Info sul continente non disponibili 2
Totale 20.881
Nazione #
US - Stati Uniti d'America 7.251
SG - Singapore 2.163
CN - Cina 1.855
VN - Vietnam 1.475
IT - Italia 1.145
GB - Regno Unito 1.135
DE - Germania 745
SE - Svezia 639
HK - Hong Kong 548
BR - Brasile 372
IN - India 327
NL - Olanda 274
RU - Federazione Russa 265
FR - Francia 257
UA - Ucraina 253
IE - Irlanda 244
KR - Corea 228
SC - Seychelles 164
CI - Costa d'Avorio 156
TG - Togo 112
FI - Finlandia 106
BG - Bulgaria 93
ZA - Sudafrica 91
JP - Giappone 90
EE - Estonia 85
NG - Nigeria 82
JO - Giordania 76
CH - Svizzera 66
AR - Argentina 62
CA - Canada 56
BE - Belgio 41
AT - Austria 35
IR - Iran 29
PL - Polonia 26
MX - Messico 24
ID - Indonesia 18
ES - Italia 15
CL - Cile 14
EC - Ecuador 14
PY - Paraguay 14
RO - Romania 14
TR - Turchia 14
BD - Bangladesh 13
LT - Lituania 13
CO - Colombia 11
EG - Egitto 9
HR - Croazia 9
IQ - Iraq 9
AU - Australia 8
UZ - Uzbekistan 8
PE - Perù 7
VE - Venezuela 7
DK - Danimarca 6
GR - Grecia 5
MA - Marocco 5
PK - Pakistan 5
UY - Uruguay 5
DO - Repubblica Dominicana 4
MK - Macedonia 4
PT - Portogallo 4
SA - Arabia Saudita 4
SI - Slovenia 4
TW - Taiwan 4
HU - Ungheria 3
IL - Israele 3
LB - Libano 3
MY - Malesia 3
OM - Oman 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AE - Emirati Arabi Uniti 2
AM - Armenia 2
AZ - Azerbaigian 2
CZ - Repubblica Ceca 2
KE - Kenya 2
KZ - Kazakistan 2
MN - Mongolia 2
NZ - Nuova Zelanda 2
PH - Filippine 2
SN - Senegal 2
TH - Thailandia 2
TN - Tunisia 2
AL - Albania 1
BO - Bolivia 1
BW - Botswana 1
CD - Congo 1
CR - Costa Rica 1
DZ - Algeria 1
GA - Gabon 1
GE - Georgia 1
GI - Gibilterra 1
GM - Gambi 1
GT - Guatemala 1
HN - Honduras 1
HT - Haiti 1
IS - Islanda 1
JM - Giamaica 1
LA - Repubblica Popolare Democratica del Laos 1
LU - Lussemburgo 1
LV - Lettonia 1
ML - Mali 1
Totale 20.877
Città #
Singapore 1.377
Southend 981
Ashburn 923
Fairfield 641
Chandler 624
Hong Kong 546
Hefei 490
Santa Clara 451
Ho Chi Minh City 318
Wilmington 302
Woodbridge 299
Seattle 297
Houston 283
Beijing 271
Ann Arbor 268
Princeton 263
Dublin 244
Hanoi 231
Seoul 222
Cambridge 212
Boardman 210
Dong Ket 205
Bologna 176
Abidjan 155
Jacksonville 145
Lomé 112
Turin 111
New York 106
Westminster 106
Los Angeles 104
Berlin 99
Milan 98
Padova 94
Nanjing 90
Sofia 89
Tokyo 84
Abeokuta 80
Bremen 79
Amman 76
Buffalo 71
Munich 71
Bern 56
Redondo Beach 53
San Diego 53
Helsinki 52
Jinan 52
Frankfurt am Main 48
Changsha 46
Rome 45
Shenyang 45
Bengaluru 43
Dallas 43
São Paulo 43
Saint Petersburg 42
Dearborn 41
Turku 41
Brussels 37
Nanchang 37
Hebei 34
Da Nang 31
Haiphong 30
Shanghai 30
Tianjin 29
Yubileyny 28
Florence 27
Mülheim 27
Pune 27
Guangzhou 26
Falkenstein 25
Medford 25
Biên Hòa 24
London 24
Toronto 24
Zhengzhou 22
Ha Long 21
Jiaxing 21
Olalla 21
Phoenix 21
Taizhou 21
Falls Church 19
Mahé 19
Mountain View 19
Paris 19
Quận Bình Thạnh 19
Chicago 18
Des Moines 18
Hangzhou 18
Norwalk 17
Nuremberg 17
Vienna 17
Kuban 16
Rio de Janeiro 16
Tongling 16
Düsseldorf 15
Lanzhou 15
Taiyuan 14
Verona 14
Can Tho 13
Haikou 13
Montreal 13
Totale 13.264
Nome #
Redo-Transcatheter Aortic Valve Implantation Using the SAPIEN 3/Ultra Transcatheter Heart Valves—Expert Consensus on Procedural Planning and Techniques 260
A Comparison Between Coronary Angioplasty and Coronary Artery Bypass Surgery for the Treatment of Unprotected Left Main Coronary Artery Stenosis (the Bologna Registry). 237
Is Pulmonary Artery Pulsatility Index (PAPi) a Predictor of Outcome after Pulmonary Endarterectomy? 229
L’angioplastica delle arterie polmonari nel cuore polmonare cronico tromboembolico: 5 anni di esperienza in Italia 229
The role of the vascular surgeon in transcatheter aortic valve implantation 228
Female gender and mortality in ST-segment-elevation myocardial infarction treated with primary PCI 224
Acute kidney injury following transcatheter aortic valve implantation: incidence, predictors and clinical outcome. 215
[Cognitive and quality of life trajectory after either surgical or transcatheter aortic valve replacement in high-risk patients] 214
[Prevalence of degenerative aortic valve stenosis in the elderly: results of a large community-based epidemiological study] 213
Incidence and Outcome of High On-Treatment Platelet Reactivity in Patients With Non-ST Elevation Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention (from the VIP [VerifyNow and Inhibition of Platelet Reactivity] Study) 210
Antithrombotic Management during Percutaneous Mitral Valve Repair with the Mitraclip System in a Patient with Heparin-Induced Thrombocytopenia 207
Baseline white blood cell count is an independent predictor of long-term cardiovascular mortality in patients with non-ST-segment elevation acute coronary syndrome, but it does not improve the risk classification of the GRACE score. 198
Clinical comparison of "normal-hours" vs "off-hours" percutaneous coronary interventions for ST-elevation myocardial infarction. 197
Cognitive functions: Evaluation and changes after transcatheter aortic valve implantation in elderly patients 195
Angioplastica delle arterie polmonari nel cuore polmonare cronico tromboembolico: un caso clinico paradigmatico 195
Vascular complications after balloon aortic valvuloplasty in recent years: Incidence and comparison of two hemostatic devices 194
Clinical relevance of homocysteine levels in patients receiving coronary stenting for unstable angina. 192
Causes and timing of death during long-term follow-up after transcatheter aortic valve replacement 186
How many patients with severe symptomatic aortic stenosis excluded for cardiac surgery are eligible for transcatheter heart valve implantation? 183
Balloon aortic valvuloplasty as a bridge-to-decision in high risk patients with aortic stenosis: A new paradigm for the heart team decision making 181
[The HEAT-PPCI study] 180
La qualità di vita dopo impianto transcatetere di valvola aortica: revisione e valutazione critica della letteratura 179
Diagnostic performance of standard electrocardiogram for prediction of infarct related artery and site of coronary occlusion in unselected STEMI patients undergoing primary percutaneous coronary intervention 177
Long-term effectiveness of early administration of glycoprotein IIb/IIIa agents to real-world patients undergoing primary percutaneous interventions: results of a registry study in an ST-elevation myocardial infarction network. 176
Optimisation of therapeutic strategies for ST-segment elevation acute myocardial infarction: the impact of a territorial network on reperfusion therapy and mortality 175
Acute kidney injury following transcatheter aortic valve implantation: incidence, predictors and 1-year clinical outcome 175
Utility of stress perfusion-cardiac magnetic resonance in follow-up of patients undergoing percutaneous coronary interventions of the left main coronary artery 175
Incidence, treatment, and outcome of acute aortic valve regurgitation complicating percutaneous balloon aortic valvuloplasty 171
Emerging indications, in-hospital and long-term outcome of balloon aortic valvuloplasty in the transcatheter aortic valve implantation era. 170
Coexistence of Degenerative Aortic Stenosis and Wild-Type Transthyretin-Related Cardiac Amyloidosis 167
Biolimus-A9 eluting stent implantion for unprotected left main coronary artery stenosis: 9-month strut coverage as assessed by optical coherence tomography 165
Coronary artery disease and reasonably incomplete coronary revascularization in high-risk patients undergoing transcatheter aortic valve implantation 165
Incidence, treatment and outcome of acute coronary syndromes: A community-based study in the era of myocardial infarction networks. 163
La rete per il trattamento dell’infarto miocardico acuto con sopraslivellamento del tratto ST in Italia. Risultati della rilevazione RETE IMA WEB 162
Clinical imaging of the vulnerable plaque in the coronary arteries: new intracoronary diagnostic methods. 162
Prognostic significance of shockable and non-shockable cardiac arrest in ST-segment elevation myocardial infarction patients undergoing primary angioplasty 161
The role of percutaneous balloon aortic valvuloplasty as a bridge for transcatheter aortic valve implantation. 157
Elevati livelli pre-procedurali della proteina C-reattiva predicono la mortalita a 9 mesi dall'angioplastica del tronco comune non protetto. 156
Short- and long-term prognostic significance of ST-segment elevation in lead aVR in patients with non-ST-segment elevation acute coronary syndrome. 156
Randomized comparative trial of a thin-strut bare metal cobalt-chromium stent versus a sirolimus-eluting stent for coronary revascularization 156
Prodromal angina and risk of 2-year cardiac mortality in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous intervention 156
The role of percutaneous aortic bloon valvuloplasty for severe degenerative aortic valve stenosis in the modern era of interventional cardiology 155
Predictors of complicated athero-thrombotic lesions in non-ST segment acute coronary syndrome. 155
Is balloon aortic valvuloplasty safe in patients with significant aortic valve regurgitation? 153
Safety and efficacy of early aggressive versus cholesterol-driven lipid-lowering strategies in heart transplantation: A pilot, randomized, intravascular ultrasound study. 152
Impact of a territorial ST-segment elevation myocardial infarction network on prognosis of patients with out-of-hospital cardiac arrest. 152
Transcatheter aortic valve implantation with a self-expanding nitinol bioprosthesis: prediction of the need for permanent pacemaker using simple baseline and procedural characteristics. 151
Pre-hospital ECG in patients undergoing primary percutaneous interventions within an integrated system of care: reperfusion times and long-term survival benefits. 150
TCT-670 Incidence, Treatment And Outcome Of Acute Aortic Valve Regurgitation Complicating Percutaneous Balloon Aortic Valvuloplasty 150
Differential effect of everolimus on progression of early and late cardiac allograft vasculopathy in current clinical practice. 150
Cardiac FDG PET/CT to Assess the Culprit Lesion during Acute Infarction 149
Cardiac FDG PET/CT is useful to assess the culprit lesion in nonST-segment elevation myocardial infarction (NSTEMI). 148
Relation between thoracic aortic inflammation and features of plaque vulnerability in the coronary tree in patients with non-ST-segment elevation acute coronary syndrome undergoing percutaneous coronary intervention. An FDG-positron emission tomography and optical coherence tomography study 148
Prognostic significance of mean platelet volume on admission in an unselected cohort of patients with non ST-segment elevation acute coronary syndrome. 148
Incidence, prognostic value and management of vascular complications with transfemoral transcatheter aortic valve implantation. 147
Risk of stroke in patients with stable coronary artery disease undergoing percutaneous coronary intervention versus optimal medical therapy: Systematic review and meta-analysis of randomized controlled trials 146
La brachiterapia endocoronarica nei pazienti diabetici con ristenosi intrastent. 145
Percutaneous mitral valve repair: The last chance for symptoms improvement in advanced refractory chronic heart failure? 144
Efficacy and safety of thrombus aspiration in ST-segment elevation myocardial infarction: an updated systematic review and meta-analysis of randomised clinical trials 143
Prognostic Relevance of Type 4a Myocardial Infarction and Periprocedural Myocardial Injury in Patients With Non–ST-Segment–Elevation Myocardial Infarction 142
Lower long-term mortality within a regional system of care for ST-elevation myocardial infarction. 142
Interplay of coronary angiography and intravascular ultrasound in predicting long-term outcomes after heart transplantation 142
Usefulness of prehospital triage in patients with cardiogenic shock complicating ST-elevation myocardial infarction treated with primary percutaneous coronary intervention 142
Riduzione del tempo di ritardo terapeutico e della mortalità ospedaliera nei pz con STEMI grazie ad un programma di accesso rapido alla PTCA primaria 141
Early vs. late IIb/IIIa agents administration in primary percutaneous interventions for ST-elevation myocardial infarction: results of a single centre registry 141
Predictive value of high sensitivity C-reactive protein in patients with ST-elevation myocardial infarction treated with percutaneos coronary intervention 141
Long-term effectiveness of early administration of IIb/IIIa agents to high-risk patients undergoing primary percutaneous interventions 138
Transcatheter Mitral Valve-in-Valve Dislocation: A Rescue Strategy 136
Therapeutic alternatives in chronic thromboembolic pulmonary hypertension: from pulmonary endarterectomy to balloon pulmonary angioplasty to medical therapy. State of the art from a multidisciplinary team 136
Differential Effect of Everolimus and Metabolic Risk Factors on Early vs. Late Progression of Allograft Vasculopathy: Dissecting Two Faces of the Same Disease 135
Randomized comparison between tirofiban and abcximab to promote complete ST-resolution in primary angioplasty: results of the facilitated angioplasty with tirofiban or abcximab (FATA) in ST-elevation myocardial infarction trial 134
Predictive value of high sensitivity C-reactive protein in patients with ST-elevation myocardial infarction treated by percutaneous coronary intervention 134
Risk of stroke in patients with high on-clopidogrel platelet reactivity to adenosine diphosphate after percutaneous coronary intervention 133
Twelve-Month Outcome of Patients with an Established Indication for Oral Anticoagulation Undergoing Coronary Artery Stenting and Stratified by the Baseline Risk of Bleeding. Insights from the Warfarin and Coronary Stenting (War-Stent) Registry 133
Pattern of arterial inflammation and inflammatory markers in people living with HIV compared with uninfected people 133
A rescue transcatheter solution for early sutureless basal ring infolding 132
How should i treat an unexpected deadlock at the time of transcatheter aortic valve prosthesis implantation? 132
Left ventricular recovery after ST-elevation myocardial infarction in patients treated with primary coronary angioplasty and abciximab or tirofiban 131
Differential Effects of Everolimus on Early vs. Late Allograft Vasculopathy Progression in Heart Transplant Recipients: a Longitudinal IVUS-Based Study 131
Standard ECG to predict culprit left main disease in unselected patients with non ST-segment elevation acute coronary syndrome 131
[Bioresorbable vascular scaffolds: clinical experience of the Emilia-Romagna Region, Italy] 130
The safety of drug-eluting stents. 128
Repeated Aortic Balloon Valvuloplasty in Elderly Patients With Aortic Stenosis Who Are Not Candidates for Definitive Treatment 128
Impact of SGLT2-inhibitors on acute kidney injury in diabetic patients with severe aortic stenosis undergoing transcatheter aortic valve implantation (TAVI) 127
Simultaneous versus staged approach in transcatheter aortic valve implantation for severe stenosis and endovascular aortic repair for thoracic and abdominal aortic aneurysm 126
SHORT AND LONG-TERM PROGNOSTIC SIGNIFICANCE OF ST-SEGMENT ELEVATION IN LEAD AVR IN PATIENTS WITH NON-ST-SEGMENT ELEVATION ACUTE CORONARY SYNDROME 126
Impact of Elective, Uncomplicated Target Lesion Revascularization on Cardiac Mortality After Elective Percutaneous Coronary Intervention of Unprotected Left Main Coronary Artery Disease 125
Ogni lungo viaggio inizia con un piccolo passo: Il Signor C e la cardiologia interventistica 124
Transcatheter aortic valve implantation for severe autograft regurgitation after Ross operation. 124
Predictors of beta-brachytherapy failure in patients with high-risk in-stent restenosis 123
One-year outcome of patients eligible to transcatheter aortic valve implantation according to actual treatment 123
Coronary Protection to Prevent Coronary Obstruction During Transcatheter Aortic Valve Replacement: A Multicenter International Registry 122
Influence of C-reactive protein on the effectiveness of IIb/IIIa agents in patients with ST-elevation myocardial infarction treated by percutaneous coronary intervention 119
Multi-imaging investigation to evaluate the relationship between serum cystatin c and features of atherosclerosis in Non-ST-Segment elevation acute coronary syndrome 119
Left ventricular function after ST-elevation myocardial infarction in patients treated with primary percutaneous coronary intervention and abciximab or tirofiban (from the Facilitated Angioplasty with tirofiban or Abciximab [FATA] trial) 118
Reply: Left Main Extrinsic Compression in Pulmonary Arterial Hypertension: From Identification to Percutaneous Coronary Intervention Optimization 116
Diagnostic performance of standard electrocardiogramfor prediction of site of coronary occlusion in unselected anterior STEMI patients 116
Predicting and improving outcomes of transcatheter aortic valve replacement in older adults and the elderly 115
Management of acute left ventricular dysfunction after primary percutaneous coronary intervention for ST elevation acute myocardial infarction 113
Impact of coronary bypass or stenting on mortality and myocardial infarction in stable coronary artery disease 113
Totale 15.672
Categoria #
all - tutte 58.193
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 58.193


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.079 0 0 0 0 0 65 31 71 159 84 66 603
2021/20222.336 179 116 132 202 182 119 46 155 80 203 505 417
2022/20233.095 270 438 165 379 251 227 75 183 575 84 271 177
2023/2024919 77 127 41 103 66 258 36 58 23 64 25 41
2024/20254.316 190 533 331 283 642 226 195 121 115 420 252 1.008
2025/20265.353 1.334 1.114 815 846 1.015 229 0 0 0 0 0 0
Totale 21.396